News Links
Press Releases for February 24, 2016
Expert Assembly Spearheaded by American Association of Clinical Endocrinologists/American College of Endocrinology Calls for Expanded Use of Continuous Glucose Monitoring Technology in the Care of People With Diabetes. JDRF Announces the Formation of a New Research Advisory Committee to Support Fight Against Type 1 Diabetes.
Read MorePopular Press for February 24, 2016
A Do-It-Yourself Revolution in Diabetes Care. Break Up the Insulin Racket. See also Eli Lilly’s revenue boosted by jacking up cost of insulin for diabetics. Insulin pumps and princesses. ‘100 things’ book and campaign launch today. Mini-Dose Glucagon May Manage Hypoglycemia for Type 1 Diabetes Patients.
Read MoreCeliac News for February 24, 2016
Decrease by 50% of plasma IgA tissue transglutaminase antibody concentrations within 2 months after start of gluten-free diet in children with celiac disease used as a confirming diagnostic test. What’s new in gluten? Rely on a pediatrician – not parental suspicion – to diagnose celiac disease and gluten intolerance.
Read MoreDaily Care News for February 24, 2016
Lower dose basal insulin infusion has positive effect on glycaemic control for children with type I diabetes on continuous subcutaneous insulin infusion therapy. The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus. Expert Study: Utility of an Automated Bolus Advisor System in Patients with Type 1 Diabetes Treated with Multiple Daily Injections of Insulin-A Crossover Study. The Stricter the […]
Read MoreResearch News From February 24, 2016
[email protected]: The Artificial Pancreas Is Now at Home. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions. Effects of Frequency of Sensor-Augmented Pump Use on HbA1c. Association between intestinal permeability and fecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes. Associations of growth patterns and islet autoimmunity in children with increased risk for type 1 diabetes: a functional analysis approach. Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 Diabetes. Endocrine autoimmunity in patients with Latent Autoimmune Diabetes in Adults (LADA) – association with HLA […]
Read MorePress Releases for February 17, 2016
CU Identifies Factor That May Trigger Type 1 Diabetes. Lilly Diabetes Helps Inspiring Students with Type 1 Diabetes Attend College Through Scholarship Donation. NICE Recommends Medtronic Integrated Sensor-Augmented Insulin Pump As the Only Therapy System to Manage Glucose Levels in Type 1 Diabetes.
Read MorePopular Press for February 17, 2016
CU Scientists Make Major Discovery In Type 1 Diabetes. Local moms design a trendy way to carry insulin pumps. New diabetes devices improve connectivity, but patient, provider education needed.
Read MoreCeliac News for February 17, 2016
Bone and Celiac Disease. Diagnosis and nursing management of coeliac disease in children. Iron deficiency anemia in newly diagnosed celiac disease in children. Evidence for the Presence of Non-Celiac Gluten Sensitivity in Patients with Functional Gastrointestinal Symptoms: Results from a Multicenter Randomized Double-Blind Placebo-Controlled Gluten Challenge. Free full text available in HTML and PDF via link.
Read MoreDaily Care News for February 17, 2016
Eating-Disordered Behavior in Adolescents with Type 1 Diabetes. Breaking the Taboo: Illicit Drug Use among Adolescents with Type 1 Diabetes Mellitus. Free full text available in HTML and PDF formats. Reduced deep sleep tied to poor glycemic control in children with type 1 diabetes. Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system). The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia […]
Read More